Makes me also wonder if the foreign part of the trial, or expanded trial, and possible large Brilacidin orders from foreign govts would put a question of what country gets Brilacidin manufactured product first - the first one(s) placing an order or the USA no matter what?

Another factor that puts FDA/USA under the gun and keeps them from wasting too much time in advancing B into EUA status.

Think this scenario shows Leo employing a very impressive strategy to get B to the marketplace.